Darwin Biosciences focuses on advancing diagnostic technologies that enable rapid detection of infections, allowing for timely and informed responses to emerging pathogens. Their approach emphasizes the importance of adapting to new challenges in infectious disease, leveraging a platform designed to evolve alongside the threats faced by human health. By prioritizing early detection, Darwin aims to provide critical knowledge that empowers individuals and organizations to implement effective action plans, ultimately enhancing public safety.

The company fosters a collaborative culture, seeking to build a team of experts dedicated to its mission of combating infectious diseases. Their work involves partnerships with governmental and institutional entities, highlighting their commitment to developing solutions that protect communities. Through their innovative research and development efforts, Darwin Biosciences is positioned as a leader in the field of infectious disease diagnostics, contributing to the broader goal of safeguarding public health on a global scale.

United States

Darwin Biosciences specializes insaliva-based diagnostic tests for infectious disease.

We are developing diagnostics that can identify people who are asymptomatic or pre-symptomatic for common infectious diseases, including COVID-19.  Some of our products are being designed for clinical use. Others are expected to be hand-held and self-administered, so that people can monitor their own health at home or when reporting for work at venues where vulnerable people (i.e. nursing homes, hospitals) or many people (delivery personnel, airport employees) are being served.

Darwin Biosciences

Company Details